VanEck Biotech ETF
BBH
52 hedge funds and large institutions have $112M invested in VanEck Biotech ETF in 2013 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 16 increasing their positions, 14 reducing their positions, and 1 closing their positions.
1,300% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 1
212% more call options, than puts
Call options by funds: $6.46M | Put options by funds: $2.07M
33% more funds holding
Funds holding: 39 → 52 (+13)
21% more capital invested
Capital invested by funds: $91.9M → $112M (+$19.7M)
14% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 14
2.1% more ownership
Funds ownership: 21.31% → 23.41% (+2.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$6.67M |
| 2 |
CM
Churchill Management
Los Angeles,
California
|
+$3.06M |
| 3 |
MCM
Murphy Capital Management
Bedminster,
New Jersey
|
+$1.25M |
| 4 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$877K |
| 5 |
NES
New England Securities
New York
|
+$871K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FMI
Factory Mutual Insurance
Waltham,
Massachusetts
|
-$4.18M |
| 2 |
NCM
Niemann Capital Management
Stateline,
Nevada
|
-$1.09M |
| 3 |
U
UBS
Zurich,
Switzerland
|
-$908K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$401K |
| 5 |
WJA
Williams Jones & Associates
New York
|
-$309K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
51
US Bancorp
Minneapolis,
Minnesota
| $13K | – | – | – |
|
|
WEC
52
Winslow Evans & Crocker
Boston,
Massachusetts
| $4K | +$4.18K | +50 | New |
|
53
Creative Planning
Overland Park,
Kansas
| – | -$6K | -75 | Closed |
|
BBH Hedge Fund Activity: Q4 2013 in Review
52 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2013, worth a combined $112M — up 21% from $91.9M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new BBH positions and 1 closed out — a net gain of 13 holders — while 16 added to existing stakes and 14 trimmed.
The largest buyer was Susquehanna International Group, adding an estimated $6.67M. The largest seller was Factory Mutual Insurance, cutting an estimated $4.18M.
- 52 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2013, up from 39 in Q3 2013.
- Funds reported $112M of VanEck Biotech ETF stock for Q4 2013, up 21% quarter-over-quarter.
- 14 funds opened new VanEck Biotech ETF positions in Q4 2013 and 1 closed out, a net change of +13 holders.
- The largest VanEck Biotech ETF buyer in Q4 2013 was Susquehanna International Group, an estimated $6.67M added.
- The largest VanEck Biotech ETF seller in Q4 2013 was Factory Mutual Insurance, an estimated $4.18M sold.
Based on aggregated 13F filings for Q4 2013.